Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezatiostat in Severe Chronic Neutropenia
NCT00909584Phase 2Terminated
- Sponsor
- Telik, Inc.
- Start
- Apr 2009
- Primary completion
- May 2013
- Countries
- 1
01
Overview
A Phase 2 trial of ezatiostat in severe chronic neutropenia (SCN), sponsored by Telik, Inc.. Started Apr 2009; status: terminated.
02
Drugs
ezatiostat
03
Conditions
severe chronic neutropenia (SCN)
Beyond the preview
Go deeper on NCT00909584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909584.